These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 5606832)

  • 21. Spatial and temporal sequence learning in patients with Parkinson's disease or cerebellar lesions.
    Shin JC; Ivry RB
    J Cogn Neurosci; 2003 Nov; 15(8):1232-43. PubMed ID: 14709239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypomyelination with atrophy of the basal ganglia and cerebellum: follow-up and pathology.
    van der Knaap MS; Linnankivi T; Paetau A; Feigenbaum A; Wakusawa K; Haginoya K; Köhler W; Henneke M; Dinopoulos A; Grattan-Smith P; Brockmann K; Schiffmann R; Blaser S
    Neurology; 2007 Jul; 69(2):166-71. PubMed ID: 17620549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A new history of basal ganglia and physiopathology of Parkinson's disease].
    Reinoso Suárez F
    An R Acad Nac Med (Madr); 2001; 118(4):771-88; discussion 788-92. PubMed ID: 12056254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Levodopa delivery systems for the treatment of Parkinson's disease: an overview.
    Goole J; Amighi K
    Int J Pharm; 2009 Oct; 380(1-2):1-15. PubMed ID: 19651197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surgery for Parkinson's disease, the five W's: why, who, what, where, and when.
    Lozano AM
    Adv Neurol; 2003; 91():303-7. PubMed ID: 12442688
    [No Abstract]   [Full Text] [Related]  

  • 26. Anatomy and physiology of the basal ganglia: implications for deep brain stimulation for Parkinson's disease.
    Kopell BH; Rezai AR; Chang JW; Vitek JL
    Mov Disord; 2006 Jun; 21 Suppl 14():S238-46. PubMed ID: 16810674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [An autopsy case of striato-nigral and olivo-ponto-cerebellar degeneration (author's transl)].
    Riku S; Hashizume Y; Yanagi T; Sobue I
    Rinsho Shinkeigaku; 1980 Jul; 20(7):534-8. PubMed ID: 7460423
    [No Abstract]   [Full Text] [Related]  

  • 28. Recent advances in Parkinson's disease: basic research. Preface.
    Björklund A; Cenci MA
    Prog Brain Res; 2010; 183():ix-x. PubMed ID: 20696311
    [No Abstract]   [Full Text] [Related]  

  • 29. Intralaminar nuclei of the thalamus in Lewy body diseases.
    Brooks D; Halliday GM
    Brain Res Bull; 2009 Feb; 78(2-3):97-104. PubMed ID: 18804518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The neurological picture of olivopontocerebellar atrophy].
    Tarnowska-Dziduszko E
    Neuropatol Pol; 1970; 8(2):169-75. PubMed ID: 5425144
    [No Abstract]   [Full Text] [Related]  

  • 31. [Features of visual contrastometry in patients with basal ganglia dysfunction].
    Iakimovskiĭ AF; Shelepin IuE; Avtonomov VV
    Fiziol Cheloveka; 1993; 19(3):47-51. PubMed ID: 8354450
    [No Abstract]   [Full Text] [Related]  

  • 32. Striatal and extrastriatal dopamine in the basal ganglia: an overview of its anatomical organization in normal and Parkinsonian brains.
    Smith Y; Villalba R
    Mov Disord; 2008; 23 Suppl 3():S534-47. PubMed ID: 18781680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MRI atrophy parameters related to cognitive and motor impairment in Parkinson's disease.
    Alegret M; Junqué C; Pueyo R; Valldeoriola F; Vendrell P; Tolosa E; Mercader JM
    Neurologia; 2001 Feb; 16(2):63-9. PubMed ID: 11257931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathophysiology of Parkinson's disease.
    Bonnet AM; Houeto JL
    Biomed Pharmacother; 1999 Apr; 53(3):117-21. PubMed ID: 10349507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spino-olivo-ponto-cerebello-nigral atrophy with Lewy bodies and binucleated nerve cells: a case report.
    Kaiya H
    Acta Neuropathol; 1974; 30(3):263-9. PubMed ID: 4374865
    [No Abstract]   [Full Text] [Related]  

  • 36. Measuring brain stem and cerebellar damage in parkinsonian syndromes using diffusion tensor MRI.
    Blain CR; Barker GJ; Jarosz JM; Coyle NA; Landau S; Brown RG; Chaudhuri KR; Simmons A; Jones DK; Williams SC; Leigh PN
    Neurology; 2006 Dec; 67(12):2199-205. PubMed ID: 17190944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease.
    Rizzo G; Martinelli P; Manners D; Scaglione C; Tonon C; Cortelli P; Malucelli E; Capellari S; Testa C; Parchi P; Montagna P; Barbiroli B; Lodi R
    Brain; 2008 Oct; 131(Pt 10):2690-700. PubMed ID: 18819991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oestrogen and nigrostriatal dopaminergic neurodegeneration: animal models and clinical reports of Parkinson's disease.
    Liu B; Dluzen DE
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):555-65. PubMed ID: 17581209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences in neuronal firing rates in pallidal and cerebellar receiving areas of thalamus in patients with Parkinson's disease, essential tremor, and pain.
    Molnar GF; Pilliar A; Lozano AM; Dostrovsky JO
    J Neurophysiol; 2005 Jun; 93(6):3094-101. PubMed ID: 15703231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [On the systematized degeneration of the centrum medianum].
    Martin JJ
    J Hirnforsch; 1967; 9(4):345-57. PubMed ID: 6062988
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.